Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 9 of 9 Projects
Project # Contact PI Funding Organization Fiscal Year
Preclinical efficacy study for antibody therapy in C9orf72 FTD/ALS mice
ADDF-30 Edbauer, Dieter Alzheimer's Drug Discovery Foundation 2020
Cerebrospinal fluid Lipocalin 2 as a specific marker of vascular dementia
GC-201810-2017419 Llorens, Franc Alzheimer's Drug Discovery Foundation 2019
Identification of an RNA-based biomarker in FTD
2019-003 Dols Icardo, Oriol The Association for Frontotemporal Degeneration 2019
ETHERAL : Epigenetic THERapy in ALzheimer’s Disease . A multicenter, multinational, randomized, double-blind, placebo-controlled, 3-arm, 26 weeks parallel-group study to evaluate the safety, tolerability of ORY-2001 in patients with mild-moderate AD
GC-201801-2014666 Bullock, Roger Alzheimer's Drug Discovery Foundation 2018
sTREM2, PGRN, and GRN as CSF markers for microglial activity, disease progression, and therapeutic target engagement
AFTD-Haass-2017 Haass, Christian The Association for Frontotemporal Degeneration 2017
Tau and adult neurogenesis. Therapeutic potential for frontotemporal degeneration
AFTD-Llorens-Martí-2017 Llorens-Martín, María The Association for Frontotemporal Degeneration 2017
Clinical development of a companion marker for treatment with the dual LSD1/MAO-B inhibitor ORY-2001
GC-2012832 Maes, Tamara Alzheimer's Drug Discovery Foundation 2016
Preclinical development of ORY-2001, a dual LSD1/MAOB inhibitor for the treatment of Alzheimer disease.
GC-2012231 Maes, Tamara Alzheimer's Drug Discovery Foundation 2015
First In Class Modifying Disease Drugs for Alzheimer's Disease
20100902 VEN-Maes-2010 Maes, Tamara Alzheimer's Drug Discovery Foundation 2010